Compass Therapeutics
CMPX
Compass Therapeutics (CMPX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $12.00 from $24.00 | Sep 23, 2026 |
| Wedbush | Downgraded | Outperform → Neutral | $1.00 from $5.00 | Sep 23, 2026 |
| Citizens | Maintained | Market Outperform | $4.00 from $10.00 | Sep 23, 2026 |
| Craig-Hallum | Maintained | Buy | $8.00 from $15.00 | Sep 23, 2026 |
| Guggenheim | Maintained | Buy | $4.00 from $8.00 | Sep 23, 2026 |
| Piper Sandler | Maintained | Overweight | $6.00 from $4.00 | Aug 7, 2026 |
| Canaccord Genuity | Maintained | Buy | $7.00 from $13.00 | Apr 28, 2026 |
| Citizens | Maintained | Market Outperform | $10.00 | Apr 28, 2026 |
| D. Boral Capital | Maintained | Buy | $30.00 | Apr 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $24.00 | Apr 27, 2026 |
| Guggenheim | Maintained | Buy | $12.00 | Mar 24, 2026 |
| D. Boral Capital | Maintained | Buy | $30.00 | Jan 6, 2026 |
| William Blair | Initiated Coverage | Outperform | — | Jan 5, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | Dec 3, 2025 |
| Canaccord Genuity | Initiated Coverage | Buy | $10.00 | Dec 3, 2025 |
| Citizens | Initiated Coverage | Market Outperform | $10.00 | Dec 3, 2025 |
| D. Boral Capital | Maintained | Buy | $30.00 | Nov 5, 2025 |
| LifeSci Capital | Initiated Coverage | Outperform | $10.00 | Oct 6, 2025 |
| D. Boral Capital | Maintained | Buy | $32.00 | Aug 12, 2025 |
| Guggenheim | Maintained | Buy | $12.00 from $10.00 | Aug 12, 2025 |
Frequently asked questions
What is the latest analyst rating on CMPX?
On Sep 23, 2026, HC Wainwright & Co. maintained Compass Therapeutics at Buy with a price target of $12.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.